Result of General Meeting & D
Sagentia Group plc ("Sagentia" or the "Company")
Result of General Meeting
&
Directors' Shareholdings
Result of General Meeting
On 18 May 2010 the Company announced that it proposed to raise, subject to certain conditions, £8.0 million (before expenses) through a placing (the "Placing") of 20,000,000 new ordinary shares of 1 pence each (the "Placing Shares") at a price of 40p per ordinary share.
The Placing was conditional, inter alia, upon the passing of certain resolutions (the "Resolutions") by shareholders to authorise the Directors to allot additional ordinary shares for cash on a non pre-emptive basis. Accordingly, a General Meeting was convened for the purpose of considering the Resolutions to approve these authorities.
The General Meeting of the Company was held earlier today and Sagentia is pleased to announce that all the Resolutions put to shareholders were duly passed.
Accordingly, application has been made to the London Stock Exchange plc for admission of the Placing Shares. Trading in the Placing Shares will be effective from 8.00 a.m. on 7 June 2010. With effect from that date, the Company's total number of ordinary shares in issue will be 41,723,595 ordinary shares, each ordinary share having equal voting rights.
Directors' shareholdings
As announced on 18 May 2010, certain of the Directors of Sagentia agreed to participate in the Placing.
Martyn Ratcliffe, the Company's Chairman, and David Courtley, a non-executive Director, have respectively subscribed for 2,000,826 and 375,000 Placing Shares at the placing price of 40p.
In addition, and again as announced on 18 May 2010, certain directors have been awarded share options pursuant to the rules of the Company's unapproved share option scheme. The share options will be allocated on the basis of 2.5 million to Martyn Ratcliffe and 1.0 million to Brent Hudson, the Company's Chief Executive Officer. These options have been issued at a price of 40 pence per ordinary share and are subject to a performance condition such that the vesting will be the later of three years from the date of grant and the share price reaching 80 pence per ordinary share for 20 consecutive trading days.
Following the above transactions, the interests of directors in the ordinary shares is as follows:
|
Name |
Shares held |
Options |
|
Martyn Ratcliffe |
12,512,906 |
2,500,000 |
|
Brent Hudson |
65,000 |
1,500,000 |
|
Guy McCarthy |
70,621 |
307,078 |
|
David Courtley |
375,000 |
0 |
For further information, please contact:
|
Sagentia Group plc |
|
|
Martyn Ratcliffe, Chairman |
Tel: +44 1223 875 200 |
|
Brent Hudson, CEO |
|
|
Guy McCarthy, CFO
|
|
|
Arbuthnot Securities Limited |
|
|
Nick Tulloch/Paul Gillam |
Tel: +44 20 7012 2000 |
Notes for Editors:
About Sagentia
Sagentia is a technology and product development company that creates, develops and delivers business opportunities, products and services for its clients.
Established in 1986, Sagentia operates in the medical, industrial products and consumer products sectors worldwide. It develops new technologies, products and services that change the basis of competition. The company also assists business leaders to create strategies for technology, innovation and growth.
Sagentia's resources are situated in state-of-the-art facilities in Europe, the USA, and China. The Group is listed on AIM (ti: SAG.L).
www.sagentia.com/investors
info@sagentia.com
This information is provided by RNS
Latest directors dealings
- 15 hours ago Savannah Energy
- 16 hours ago Buccaneer Energy PLC
- 17 hours ago Savannah Energy
- 17 hours ago Carclo
- 17 hours ago Schroder Japan Growth Fund